LNTH News and Press, Lantheus Holdings Inc. From 12/18/23

2023-12-18 23:16:26 ET Summary Lantheus stock dropped 26% post-SPLASH study, highlighting risks in mCRPC drug development and its strategic alliance with POINT Biopharma. SPLASH trial met primary goals but showed underwhelming overall survival data, affecting investor confidence a...

2023-12-18 14:00:05 ET Summary Eli Lilly and Company wants to acquire POINT Biopharma Global Inc. with a tender offer of $12.5/share, which represented an 87% premium. POINT Biopharma Global is trading at $12.45, just $0.05 above the take-out price, and the tender offer could wrap...

2023-12-18 09:22:49 ET More on Lantheus, POINT Biopharma Global, etc. POINT Biopharma Global: Why The Market Believes That A Second Bidder May Emerge Lantheus Holdings: Huge Catalysts Ahead And Cheap Valuation Lantheus Holdings, Inc. (LNTH) Q3 2023 Earnings Call Tran...

2023-12-17 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-12 08:36:13 ET Summary Lantheus experienced tremendous growth in the last two years thanks to the approval of a new imaging agent called PYLARIFY. The company now faces several catalysts including the approval of PYLARIFY in Europe and the commercialization of PNT2002 and ...

2023-11-03 06:10:25 ET Lantheus Holdings, Inc. (LNTH) Q3 2023 Earnings Conference Call November 02, 2023, 08:00 AM ET Company Participants Mark Kinarney - Vice President of Investor Relations Mary Anne Heino - Chief Executive Officer Paul Blanchfield - President ...

2023-11-02 07:09:05 ET More on Lantheus Lantheus: Fast-Growing Radiotherapeutics Specialist Can Benefit From Lilly's POINT Biopharma Takeover Lantheus: Growth Well Priced In, Profitability Next Hurdle (Rating Downgrade) Lantheus: Not Quite Ready To Take The Plunge ...

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Worldwide revenue of $319.9 million for the third quarter 2023, representing an increase of 33.7% from the prior year period GAAP net income of $132.0 million for the third quarter 2023, compared to GAAP net income of $61.2 million in the prior year period GAAP fully diluted net i...

Lantheus Holdings Inc. (LNTH) is expected to report $1.19 for Q3 2023